Immunic Inc (IMUX): Total Asset Value of Company
Immunic, Inc. (IMUX) faces risks associated with patent disputes and logistical challenges in sourcing raw materials from abroad. This price trajectory reflects total assets at 110.30. The company is seeking support from industry behemoths to complete clinical trials, as its acquisition budget remains limited. Business stability relies on life-saving therapy, which is not subject to economic cycles.
Comprehensive metric breakdowns and analytics for immunic-therapeutics.com (IMUX)
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
Fundamental valuation:IMUX, Immunic Inc
The dynamics of Immunic, Inc. (IMUX) total resources, calculated reverse-engineered through return on assets (ROA), allow for the identification of hidden business degradation or an expansion phase relative to competitors. By analyzing balance sheet assets, an investor assesses the material base of Immunic, Inc., which must enable the scaling of lifetime multiple sclerosis therapy production to generate stable, long-term cash flows.
Competitors of Immunic, Inc. (IMUX)
ARGX (argenx.com) - Total Business Assets|Aggregate Company Assets BioNTech BNTX|Total Asset Value of Company Abivax|ADMA Bio (ADMA) - Company Total Assets|Aggregate Asset Value Protagonist Corp (PTGX)|Company Total Assets IMVT (Immunovant, Inc.)|kiniksa.com - Company Total Assets|Aggregate Company Assets Grifols (GRFS)|ADPT: Aggregate Asset Value|CLDX (Celldex) - Aggregate Company Assets|Aurinia Corp (AUPH) - Cumulative Company Assets|BCRX (BioCryst) - Company Total Assets|Company Total Assets veratx.com (VERA)|Dianthus Therapeutics, Inc. (DNTH) - Cumulative Company Assets|Aggregate Asset Value Pharvaris NV (PHVS)|Company Total Assets ABCL|Tourmaline - Company Total Asset Base|PGEN: Aggregate Company Assets|PHAR: Cumulative Company Assets|NKTR (Nektar Therapeutics Inc.) - Aggregate Company Assets|Cumulative Company Assets Upstream Bio, Inc.|ZBIO (Zenas Biopharma, Inc.) - Cumulative Company Assets|Company Total Assets IMNM|Aggregate Company Assets Gossamer Bio, Inc. GOSS|Total Business Assets kalvista.com (KALV)|SEPN: Company Total Assets|Company Assets Pieris Pharma PVLA|Company Total Assets SVRA (Savara Corp)|RIGL: Company Total Asset Base|ANAB (AnaptysBio, Inc.) - Aggregate Company Assets|ATXS (astriatx.com) - Cumulative Company Assets|Aggregate Company Assets ENGN|Cumulative Company Assets RAPT Therapeutics Inc. (RAPT)|Cumulative Company Assets JBIO|Company Total Assets ACRS (Aclaris Therapeutics, Inc)|KYTX - Aggregate Company Assets|Total Business Assets tizianalifesciences.com TLSA|Company Total Assets CABA (Cabaletta Bio)|VTYX - Company Total Asset Base|THTX (Theratechnologies Inc) - Company Total Assets|Cumulative Company Assets Avalo Therapeutics Inc|ELDN - Cumulative Company Assets|Aggregate Asset Value agenusbio.com|CLYM (Climb Bio) - Company Total Assets|Company Total Asset Base ZURA (Zura Bio Ltd)|ATYR - Aggregate Company Assets|Total Business Assets Adagene Inc ADAG|IMA: Company Total Assets|Shattuck Labs, Inc. (STTK) - Cumulative Company Assets|equilliumbio.com - Cumulative Company Assets|Connect Biopharma Holdings Limited (CNTB) - Company Total Asset Base|ATRA: Company Total Assets|Company Total Asset Base IFRX|Aggregate Company Assets XFOR (X4 Pharmaceuticals)|Cumulative Company Assets adicetbio.com ACET|Cumulative Company Assets CELU (Celularity)|INMB - Company Total Assets|Barinthus Bio (BRNS) - Cumulative Company Assets|KZR: Total Business Assets|Aggregate Company Assets SAB Biotherapeutics (SABS)|akaritx.com (AKTX) - Total Asset Value of Company|ENLV - Company Total Assets|Aggregate Asset Value Q32 Bio Corp|Company Total Assets GOVX|Company Total Assets EDSA (Edesa Biotech Corp)|Aggregate Company Assets iBio, Inc.|Carisma Therapeutics Inc - Aggregate Asset Value|XTLB: Aggregate Company Assets|BOLT - Cumulative Company Assets|HCWB: Company Total Assets|Company Total Assets Aptevo Therapeutics Inc.|AIM - Cumulative Company Assets|Aggregate Asset Value Aditxt Corp|GRI (GRI Bio) - Company Total Assets|Company Total Asset Base XRTX (XORTX Therapeutics Inc)|ReShape Lifesciences - Aggregate Company Assets|Revelation Biosciences Corp - Cumulative Company Assets|INDP: Aggregate Company Assets|scinai.com (SCNI) - Cumulative Company Assets|CALI: Cumulative Company Assets|AFMD (Affimed N.V.) - Company Total Assets|Aggregate Company Assets Allakos Inc (ALLK)|Total Business Assets HOOKIPA|IGM Biosciences, Inc. - Company Total Assets|Company Assets iteostherapeutics.com (ITOS)|Company Total Assets OCEA|TC BioPharm (Holdings) Plc - Company Total Asset Base|THRD: Aggregate Company Assets